NASDAQ$PLXS

Plexus Corp · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Reported fiscal second quarter revenue of $967 million and non-GAAP EPS of $0.94.

Plexus reported fiscal second quarter revenue of $967 million and non-GAAP EPS of $0.94, which met the top end of guidance. The company generated free cash flow of $65 million.

  • Won 32 manufacturing programs during the quarter representing $255 million in annualized revenue when fully ramped into production.
  • Purchased $17.6 million of shares at an average price of $94.39 per share under repurchase programs.
  • Generated free cash flow of $65 million.
  • Cash cycle of 91 days, 10 days favorable to expectations and sequentially lower by four days.

Headline financials

Total Revenue

$998M

Previous: $1.1B-9.1%
EPS

$0.58

Previous: $1.45-60.0%
Capital Expenditures

-$51.5M

Previous: -$49.5M-4.1%
Free Cash Flow

-$35.3M

Previous: -$8.65M-308.0%
Net Income

$16.2M

Previous: $40.8M-60.2%
Operating Income

$29.5M

Previous: $56.9M-48.2%
Gross Profit

$88.1M

Previous: $103M-14.5%
Cash & Equivalents

$265M

Previous: $270M-1.7%
Total Assets

$3.28B

Previous: $3.38B-3.1%
Stock-Based Comp

$7.51M

Previous: $5.8M+29.5%

Revenue & EPS history

Plexus · Revenue · Quarterly

$998M

Q2 2024-9.1%vs Q2 2023
Beat estimate in 7 of 15 quarters(47%)
ActualEstimate

Revenue by segment

Plexus · $946M total across 2 segments · Q4 2023

  • Asia-Pacific
    $557M
  • Americas
    $389M

Forward guidance

Plexus is guiding fiscal third quarter revenue of $960 million to $1.00 billion, non-GAAP operating margin of 5.2% to 5.6% and non-GAAP EPS of $1.22 to $1.37.

Tailwinds

  • Revenue growth is in the early stages of inflecting higher.
  • Benefiting from robust demand within the Aerospace and Defense market sector.
  • Gradually recovering semiconductor capital equipment demand.
  • New program ramps are mitigating inventory correction headwinds in Healthcare/Lifesciences.
  • New program ramps are mitigating inventory correction headwinds in Industrial market sectors.

Headwinds

  • Non-GAAP operating margin excludes approximately $6.5 million of restructuring charges associated with realigning manufacturing capabilities to best support long-term customer needs
  • Non-GAAP operating margin excludes approximately $6.2 million of stock-based compensation expense.
  • Inventory correction headwinds in Healthcare/Lifesciences market sectors.
  • Inventory correction headwinds in Industrial market sectors.
  • Restructuring charges associated with realigning manufacturing capabilities.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-0.1%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+2.5%

Avg return

30 days after

51%

35 / 68 earnings

Positive

+13.2%

Q1 2016

Best reaction

-18.1%

Q1 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026+2.7%+5.8%+7.1%
Q1 2026+9.3%+12.7%+7.3%
Q4 2025+2.8%-1.7%-5.2%
Q2 2025-1.4%-1.1%+1.9%
Q1 2025-10.1%-15.2%-19.4%
Q4 2024+7.5%+6.3%+20.2%
Q3 2024+9.0%+6.3%+7.7%
Q2 2024+2.6%+5.9%+17.3%
Q1 2024-5.1%-6.7%-4.2%
Q4 2023+5.9%+9.4%+17.8%
Q3 2023-3.9%-3.9%-2.9%
Q2 2023-0.5%+0.0%+5.4%
Q1 2023-18.1%-19.6%-16.1%
Q4 2022-1.2%+1.4%+11.7%
Q3 2022+6.5%+9.6%+9.9%
Q2 2022+6.2%+6.5%+9.2%
Q1 2022-6.0%-2.3%+2.8%
Q4 2021-8.0%-5.8%-9.8%
Q3 2021-0.3%+1.4%+2.8%
Q2 2021-1.0%+4.0%+8.9%
Q1 2021-3.7%-3.2%+0.6%
Q4 2020-3.3%-1.2%+8.7%
Q3 2020+2.8%-1.6%+3.4%
Q2 2020+7.0%+9.9%+14.7%
Q1 2020+2.6%-3.2%-7.6%
Q4 2019+9.1%+13.0%+15.4%
Q3 2019-9.1%-8.4%-7.1%
Q2 2019-7.8%-8.8%-17.5%
Q1 2019-2.1%+1.6%+9.3%
Q4 2018+4.1%+3.1%+4.8%
Q3 2018-0.5%-1.5%-1.7%
Q2 2018-11.6%-11.4%-6.3%
Q1 2018-5.7%-6.0%-7.2%
Q4 2017+5.8%+4.9%+8.4%
Q3 2017+3.5%+3.2%-6.2%
Q2 2017-6.8%-7.7%-13.0%
Q1 2017+0.4%-0.0%+8.1%
Q4 2016+1.3%+2.3%+14.7%
Q3 2016-2.2%-0.4%+2.1%
Q2 2016+7.6%
Q1 2016+13.2%
Q4 2015-12.4%
Q3 2015-6.2%
Q2 2015+0.8%
Q1 2015-0.7%
Q4 2014+5.2%
Q3 2014-3.7%
Q2 2014+9.2%
Q1 2014-3.3%
Q4 2013+3.1%
Q3 2013-1.7%
Q2 2013+0.0%
Q1 2013+6.0%
Q4 2012-0.3%
Q3 2012+4.9%
Q2 2012-2.2%
Q1 2012+2.1%
Q3 2009+0.3%
Q4 2011+0.3%
Q3 2011-13.6%
Q2 2011+1.4%
Q1 2010+1.3%
Q1 2011+2.7%
Q2 2010-1.6%
Q4 2008-1.6%
Q4 2010-1.6%
Q4 2009+0.2%
Q3 2010+0.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro